Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I)

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2020
INTERVENTION: Intervention1: Group I: Ayurveda intervention AYUSH‐64 as add‐on to standard treament: AYUSH 64: 2 Tablets (500mg each) thrice daily with water after meal for 1 month Control Intervention1: Group II: Standard treatment for COVID‐19 infection: Standard treatments for COVID‐19 infection as per Maharashtra guidelines CONDITION: Health Condition 1: B972‐ Coronavirus as the cause of diseases classified elsewhere PRIMARY OUTCOME: 1.Clinical cure rate: Time to negative conversion of severe acute respiratory syndrome corona‐virus 2.Timepoint: At baseline, 4 weeks SECONDARY OUTCOME: 1.Duration of fever and each of the respiratory symptoms. ; 2.Improvement in hematological and laboratory parameters (CBC, LFT, RFT, RBS, ESR, Hs‐CRP, LDH, CXR, ABG, S. Ferritin, D‐dimer, ECG). ; 3.No of cases Reporting any ADR/AE. ; 4.Number of patients referred. ; 5.Number of cases that required invasive or non‐invasive oxygen therapy during the intervention. ; 6.Number of cases that progressed to multi‐organ failure while under clinical trial.Timepoint: 1 Month INCLUSION CRITERIA: 1.Patients of 18‐60 yrs of age, clinically diagnosed with corona virus disease 2019 by RTPCR test coming under stage I‐ mild (Early infection)‐ Group A, B, C as per TREATMENT PROTOCOL FOR CONFIRMED COVID‐19 PATIENTS (Maharashtra Health Services_15 April 2020.) 2.Participants who can take medicines orally. 3.Patients willing to provide signed informed consent.
Epistemonikos ID: c707adfcb917c14a34b53e9887979aba4f15bfdb
First added on: Jun 24, 2020